FDA guidance plans revealed
This article was originally published in The Gray Sheet
Executive Summary
Stakeholder ideas for device guidance development and revisions are solicited in July 9 Federal Register notice detailing 1FDA's annual guidance document agenda. The list, which outlines agency-wide guidance plans including device and biologic center documents and contacts, "represents possible new topics or revisions to existing guidance documents that the agency is considering"...